Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval

GlobalData analysts predicts that the myostatin inhibitor drug class will be a key driver of growth within the SMA market in years to come.

Annabel Kartal Allen

PremiumNews

Pressure intensifies on Novartis as bolt-on deal strategy faces major test

Robert Barrie

News

HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir

Robert Barrie

PremiumAnalyst Comment

ERS 2026: BMI, type-2 inflammation, and asthma attack risk

PremiumFeatures

Staunch biotech competition spurs new secretive tactics, shifts investor approach

News

Exegenesis Bio and Modalis sign research deal for Duchenne therapy

News

ABEC to expand global manufacturing network with new Wilson facility

Features

Podcast: key readouts from ESC and ERS

Analysis

PremiumAnalyst Comment

ERS 2026: GB-0895 clinical results show potential of next-gen anti-TSLP for asthma

GlobalData Healthcare

PremiumAnalyst Comment

ERS 2026: AstraZeneca’s IL-33 inhibitor tozorakimab reduces mucus plug burden in COPD

GlobalData Healthcare

PremiumFeatures

Osaka has the science. Now it needs the business

Catherine Longworth

PremiumAnalyst Comment

ESC 2026: oral and injectable GLP-1 comparisons under the spotlight

GlobalData Healthcare

Themes

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

With regulatory conditions tightening around climate impact and environmental persistence of medical propellants, HFA-152a is a practical route to maintain clinical performance, patient outcomes and supply continuity of inhalers. However,...

More themes

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Partner Content

Turning AI skeptics into AI advocates through high-integrity data

Partner Content

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Hodgkin Lymphoma: Epidemiology Report and Forecast

$9995.00

Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Pressure intensifies on Novartis as bolt-on deal strategy faces major test

HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir

ERS 2026: BMI, type-2 inflammation, and asthma attack risk

Staunch biotech competition spurs new secretive tactics, shifts investor approach

Exegenesis Bio and Modalis sign research deal for Duchenne therapy

ABEC to expand global manufacturing network with new Wilson facility

Podcast: key readouts from ESC and ERS

ERS 2026: GB-0895 clinical results show potential of next-gen anti-TSLP for asthma

ERS 2026: AstraZeneca’s IL-33 inhibitor tozorakimab reduces mucus plug burden in COPD

Osaka has the science. Now it needs the business

ESC 2026: oral and injectable GLP-1 comparisons under the spotlight

Industry partnership will determine the success of the transition to low-GWP pMDIs

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Hodgkin Lymphoma: Epidemiology Report and Forecast

Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Membranous Glomerulonephritis - Global Clinical Trials Review, 2026

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

Multiple Myeloma (Kahler Disease) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Hodgkin Lymphoma: Epidemiology Report and Forecast

Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Membranous Glomerulonephritis - Global Clinical Trials Review, 2026

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

Multiple Myeloma (Kahler Disease) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing